{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:54:43Z","timestamp":1792173283022,"version":"4.4.0"},"reference-count":123,"publisher":"Tech Science Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2024.053069","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T08:11:00Z","timestamp":1727079060000},"page":"15-26","source":"Crossref","is-referenced-by-count":17,"title":["Engendered nanoparticles for treatment of brain tumors"],"prefix":"10.32604","volume":"33","author":[{"given":"SOROUSH","family":"SOLEYMANI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KIARASH","family":"ASGARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ASO","family":"MOBARAKSHAHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARYANA","family":"AGHAEIPOUR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MOHAMMAD","family":"DOROUDIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAHDIEH","family":"SOEZI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALI","family":"BELADI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RONAN","family":"MACLOUGHLIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/chemosensors8040117","article-title":"Nanomaterials for diagnosis and treatment of brain cancer: recent updates","volume":"8","author":"Mukhtar","year":"2020","journal-title":"Chemosensors"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00247-020-04794-y","article-title":"Superficial anatomy of the neonatal cerebrum\u2014an ultrasonographic roadmap","volume":"51","author":"Gon\u00e7alves","year":"2021","journal-title":"Pediatr Radiol"},{"key":"ref3","unstructured":"Zhang JW. Secrets of the brain: an introduction to the brain anatomical structure and biological function. 2019. doi:10.48550\/arXiv.1906.03314."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cancers12010242","article-title":"Nano-therapies for glioblastoma treatment","volume":"12","author":"Alphand\u00e9ry","year":"2020","journal-title":"Cancers"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J Control Release"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm Res"},{"key":"ref7","author":"Stiller","year":"2020","journal-title":"Oxford textbook of cancer in children"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.23736\/S0390-5616.19.04701-5","article-title":"The management of low-grade gliomas in adults","volume":"63","author":"Morshed","year":"2019","journal-title":"J Neurosurg Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem Soc Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/jcp.29126","article-title":"Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers","volume":"235","author":"Aghebati-Maleki","year":"2020","journal-title":"J Cell Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-11-1","article-title":"Magnetic core-shell nanoparticles for drug delivery by nebulization","volume":"11","author":"Verma","year":"2013","journal-title":"J Nanobiotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/diagnostics12010173","article-title":"Nanoparticles for diagnosis and target therapy in pediatric brain cancers","volume":"12","author":"Guido","year":"2022","journal-title":"Diagnostics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1567201816666191029122740","article-title":"Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges","volume":"16","author":"Kashyap","year":"2019","journal-title":"Curr Drug Deliv"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tifs.2019.10.002","article-title":"Nanoencapsulated nisin: an engineered natural antimicrobial system for the food industry","volume":"94","author":"Bahrami","year":"2019","journal-title":"Trends Food Sci Technol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"103565","DOI":"10.1016\/j.critrevonc.2021.103565","article-title":"Emerging role of exosomes as biomarkers in cancer treatment and diagnosis","volume":"169","author":"Hanjani","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2217\/epi-2020-0026","article-title":"Exosomal microRNAs: novel players in cervical cancer","volume":"12","author":"Nahand","year":"2020","journal-title":"Epigenomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"957572","DOI":"10.3389\/fchem.2022.957572","article-title":"Nanocarriers: a novel strategy for the delivery of CRISPR\/Cas systems","volume":"10","author":"Hejabi","year":"2022","journal-title":"Front Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"113043","DOI":"10.1016\/j.colsurfb.2022.113043","article-title":"Nanotechnology as a tool to overcome macromolecules delivery issues","volume":"222","author":"Tundisi","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00018-011-0856-6","article-title":"Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications","volume":"69","author":"Galvin","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.3390\/molecules24234312","article-title":"Nasal drug delivery of anticancer drugs for the treatment of glioblastoma: preclinical and clinical trials","volume":"24","author":"Bruinsmann","year":"2019","journal-title":"Molecules"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"786700","DOI":"10.3389\/fphar.2021.786700","article-title":"Nanotherapeutics overcoming the blood-brain barrier for glioblastoma treatment","volume":"12","author":"Tang","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"678593","DOI":"10.3389\/fmedt.2021.678593","article-title":"Targeting non-coding RNA for glioblastoma therapy: the challenge of overcomes the blood-brain barrier","volume":"3","author":"Sharma","year":"2021","journal-title":"Front Med Technol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.copbio.2019.01.013","article-title":"Exploiting BBB disruption for the delivery of nanocarriers to the diseased CNS","volume":"60","author":"Umlauf","year":"2019","journal-title":"Curr Opin Biotechnol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3762\/bjnano.11.72","article-title":"Key for crossing the BBB with nanoparticles: the rational design","volume":"11","author":"Lombardo","year":"2020","journal-title":"Beilstein J Nanotechnol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"2020","journal-title":"J Control Release"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.2147\/DDDT.S218708","volume":"13","author":"Bagchi","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/pharmaceutics13081193","article-title":"Emerging nano-carrier strategies for brain tumor drug delivery and considerations for clinical translation","volume":"13","author":"Lundy","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref35","first-page":"683","article-title":"Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain","volume":"6","author":"Pardridge","year":"2003","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1002\/wnan.1695","article-title":"Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases","volume":"13","author":"Zhou","year":"2021","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165-166","author":"Pandit","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/pharmaceutics13111972","article-title":"Smart nanotherapeutics and lung cancer","volume":"13","author":"Doroudian","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/6493458","article-title":"Applications of iron oxide nanoparticles against breast cancer","volume":"2022","author":"Hosseinkazemi","year":"2022","journal-title":"J Nanomater"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1144653","DOI":"10.3389\/fbioe.2023.1144653","article-title":"Nanomedicine in lung cancer immunotherapy","volume":"11","author":"Doroudian","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","article-title":"Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics","volume":"13","author":"Bergmann","year":"2018","journal-title":"Nat Protoc"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"28928","DOI":"10.1021\/acsami.0c14625","article-title":"Penetrating the blood-brain barrier by self-assembled 3D DNA nanocages as drug delivery vehicles for brain cancer therapy","volume":"12","author":"Tam","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"113999","DOI":"10.1016\/j.addr.2021.113999","article-title":"Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies","volume":"179","author":"Karlsson","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1039\/D0BM01536A","article-title":"Development of curcumin-loaded zein nanoparticles for transport across the blood-brain barrier and inhibition of glioblastoma cell growth","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.csbj.2019.09.004","article-title":"Recent advancements in non-invasive formulations for protein drug delivery","volume":"17","author":"Bajracharya","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/IJN.S231479","article-title":"Overcoming the blood-brain barrier: successes and challenges in developing nanoparticle-mediated drug delivery systems for the treatment of brain tumours","volume":"15","author":"Ferraris","year":"2020","journal-title":"Int J Nanomed"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/thoraxjnl-2019-213037","article-title":"Nanotechnology based therapeutics for lung disease","volume":"74","author":"Doroudian","year":"2019","journal-title":"Thorax"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coph.2020.11.002","article-title":"Nanotechnology in pulmonary medicine","volume":"56","author":"Doroudian","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"ref51","first-page":"140","article-title":"Smart lipid-based nanoparticles in lung cancer treatment: current status and future directions","volume":"6","author":"Shahrivar","year":"2023","journal-title":"Adv Ther"},{"key":"ref52","first-page":"1944","article-title":"Receptor-assisted nanotherapeutics for overcoming the blood-brain barrier","volume":"26","author":"Mhaske","year":"2024","journal-title":"Mol Neurobiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"119491","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1166\/jnn.2015.10298","article-title":"Applications of nanoparticles for anticancer drug delivery: a review","volume":"15","author":"Zhu","year":"2015","journal-title":"J Nanosci Nanotechnol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"952675","DOI":"10.3389\/fchem.2022.952675","article-title":"Physically stimulus-responsive nanoparticles for therapy and diagnosis","volume":"10","author":"Farjadian","year":"2022","journal-title":"Front Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ces.2014.06.042","article-title":"Smart nanoparticles for drug delivery: boundaries and opportunities","volume":"125","author":"Lee","year":"2015","journal-title":"Chem Eng Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/j.1552-4604.1998.tb04464.x","article-title":"AmBisome (liposomal amphotericin B): a comparative review","volume":"38","author":"Boswell","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1629865","DOI":"10.1080\/20013078.2019.1629865","article-title":"Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis","volume":"8","author":"Zeng","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.2174\/0929867329666220527121943","article-title":"Applications of gold nanoparticles in brain diseases across the blood-brain barrier","volume":"29","author":"Zhang","year":"2022","journal-title":"Curr Med Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","article-title":"Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy","volume":"88","author":"Papahadjopoulos","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1073\/pnas.0707046105","article-title":"Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jconrel.2022.03.007","article-title":"Blood-brain barrier crossing using magnetic stimulated nanoparticles","volume":"345","author":"Chen","year":"2022","journal-title":"J Control Release"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/pharmaceutics14102237","article-title":"Blood-brain barrier transport of transferrin receptor-targeted nanoparticles","volume":"14","author":"Thomsen","year":"2022","journal-title":"Pharmaceutics"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2012.04.018","volume":"161","author":"Yudina","year":"2012","journal-title":"J Control Release"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2013.03.024","article-title":"Real-time imaging and kinetics measurements of focused ultrasound-induced extravasation in skeletal muscle using SPECT\/CT","volume":"168","author":"Sanches","year":"2013","journal-title":"J Control Release"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.2147\/DDDT.S219489","article-title":"Smart targeting to improve cancer therapeutics","volume":"13","author":"Morales-Cruz","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/10717544.2019.1710623","volume":"27","author":"Kou","year":"2020","journal-title":"Drug Deliv"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s11051-014-2304-7","article-title":"Targeted polymeric nanoparticles containing gold nanorods: a therapeutic approach against glioblastoma","volume":"16","author":"Locatelli","year":"2014","journal-title":"J Nanopart Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1021\/acs.chemmater.7b02567","article-title":"Target-or-clear zirconium-89 labeled silica nanoparticles for enhanced cancer-directed uptake in melanoma: a comparison of radiolabeling strategies","volume":"29","author":"Chen","year":"2017","journal-title":"Chem Mater"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/pmic.201200252","article-title":"On-target and nanoparticle-facilitated selective enrichment of peptides and proteins for analysis by MALDI-MS","volume":"12","author":"Stolowitz","year":"2012","journal-title":"Proteomics"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbrc.2020.10.076","article-title":"Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB","volume":"534","author":"Zhu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4161\/21645515.2014.980686","article-title":"DNA vaccine for cancer immunotherapy","volume":"10","author":"Yang","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccines: an historical perspective and view to the future","volume":"239","author":"Liu","year":"2011","journal-title":"Immunol Rev"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/acs.molpharmaceut.0c00709","article-title":"RNA interference nanotherapeutics for treatment of glioblastoma multiforme","volume":"17","author":"Singh","year":"2020","journal-title":"Mol Pharm"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/14712598.2010.481667","article-title":"RNA interference therapy for glioblastoma","volume":"10","author":"Guo","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/14712598.2016.1212012","article-title":"Recent advances and future of immunotherapy for glioblastoma","volume":"16","author":"Kamran","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/neuonc\/nou212","article-title":"Immunotherapy advances for glioblastoma","volume":"16","author":"Reardon","year":"2014","journal-title":"Neuro Oncol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneurol.2015.139","article-title":"Prospects of immune checkpoint modulators in the treatment of glioblastoma","volume":"11","author":"Preusser","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/PPO.0b013e31824671c9","article-title":"Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates","volume":"18","author":"Wollmann","year":"2012","journal-title":"Cancer J"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1566523033347426","article-title":"Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene\/Ganciclovir system: fifteen years of application","volume":"3","author":"Fillat","year":"2003","journal-title":"Curr Gene Ther"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1089\/hum.1997.8.15-1807","article-title":"A \u201cdistant\u201d bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor","volume":"8","author":"Kianmanesh","year":"1997","journal-title":"Hum Gene Ther"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000","journal-title":"Hum Gene Ther"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archotol.1996.01890190042011","article-title":"HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect","volume":"122","author":"Wilson","year":"1996","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.ctrv.2019.101896","article-title":"Molecular targeted therapy of glioblastoma","volume":"80","author":"Le Rhun","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fonc.2019.00963","article-title":"Glioblastoma multiforme: an overview of emerging therapeutic targets","volume":"9","author":"Taylor","year":"2019","journal-title":"Front Oncol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"106522","DOI":"10.1016\/j.phrs.2022.106522","article-title":"Endogenous stimuli-responsive nanoparticles for cancer therapy: from bench to bedside","volume":"186","author":"Xie","year":"2022","journal-title":"Pharmacol Res"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.3390\/molecules27238495","article-title":"Stimuli-responsive polypeptide nanoparticles for enhanced DNA delivery","volume":"27","author":"Korovkina","year":"2022","journal-title":"Molecules"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/pharmaceutics14112346","article-title":"Tumor microenvironment-based stimuli-responsive nanoparticles for controlled release of drugs in cancer therapy","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1039\/D2NR05218K","article-title":"Polypropylene sulphide coating on magnetic nanoparticles as a novel platform for excellent biocompatible, stimuli-responsive smart magnetic nanocarriers for cancer therapeutics","volume":"15","author":"Chauhan","year":"2023","journal-title":"Nanoscale"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.30574\/gscbps.2022.20.1.0259","article-title":"Polymeric nanoparticles with stimuli-responsive properties for drug delivery","volume":"20","author":"Seelam","year":"2022","journal-title":"GSC Biol Pharm Sci"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J Cell Sci"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phrs.2017.05.004","article-title":"Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy","volume":"126","author":"Yang","year":"2017","journal-title":"Pharmacol Res"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","article-title":"Peptide-drug conjugates with different linkers for cancer therapy","volume":"64","author":"Alas","year":"2021","journal-title":"J Med Chem"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/bc9005656","article-title":"Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release","volume":"21","author":"Chen","year":"2010","journal-title":"Bioconjug Chem"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"16778","DOI":"10.1021\/ja805570f","article-title":"Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery","volume":"130","author":"Chen","year":"2008","journal-title":"J Am Chem Soc"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2017.02.006","article-title":"Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides","volume":"250","author":"Dissanayake","year":"2017","journal-title":"J Control Release"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"ref103","first-page":"e50062","author":"Radu","year":"2013","journal-title":"J Vis Exp"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","article-title":"Cancer active targeting by nanoparticles: a comprehensive review of literature","volume":"141","author":"Bazak","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2013.09.006","article-title":"Multifunctional nanoparticles for brain tumor imaging and therapy","volume":"66","author":"Cheng","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/B978-0-12-394447-4.40043-X","article-title":"Drug targeting","volume":"4","author":"Longden","year":"2016","journal-title":"Encycl Cell Biol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.2174\/092986712800784702","article-title":"Drug-loaded nanocarriers: passive targeting and crossing of biological barriers","volume":"19","author":"M.Rabanel","year":"2012","journal-title":"Curr Med Chem"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"571394","DOI":"10.5402\/2012\/571394","article-title":"Targeted delivery of nanomedicines","volume":"2012","author":"Kumar Khanna","year":"2012","journal-title":"ISRN Pharmacol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-030-06115-9_6","author":"Patel","year":"2019","journal-title":"Surface modification of nanoparticles for targeted drug delivery"},{"key":"ref111","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-41129-3","author":"Bhatia","year":"2016","journal-title":"Natural polymer drug delivery systems: nanoparticles, plants, and algae"},{"key":"ref112","first-page":"328","article-title":"A review on targeted drug delivery: its entire focus on advanced therapeutics and diagnostics","volume":"2","author":"Rani","year":"2014","journal-title":"Sch J App Med Sci"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"100370","DOI":"10.1016\/j.nanoso.2019.100370","article-title":"Active targeting drug delivery nanocarriers: ligands","volume":"19","author":"Anarjan","year":"2019","journal-title":"Nano-Struct Nano-Objects"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/21691401.2018.1457039","article-title":"Nanoparticles as carriers for drug delivery in cancer","volume":"46","author":"Dadwal","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-00477-3_1","article-title":"Passive and active drug targeting: drug delivery to tumors as an example","volume":"197","author":"Torchilin","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/cancers11050640","article-title":"Active targeting strategies using biological ligands for nanoparticle drug delivery systems","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J Control Release"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-801238-3.99883-0","author":"Morshed","year":"2019","journal-title":"Encyclopedia of biomedical engineering"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","article-title":"Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine","volume":"30","author":"Pearce","year":"2019","journal-title":"Bioconjug Chem"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14737140.7.6.833","article-title":"Nanotechnology for targeted cancer therapy","volume":"7","author":"Wang","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1359-6446(03)02988-X","article-title":"Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress","volume":"9","author":"Marcucci","year":"2004","journal-title":"Drug Discovery Today"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/pharmaceutics10040181","article-title":"Targeted theranostic nanoparticles for brain tumor treatment","volume":"10","author":"Mendes","year":"2018","journal-title":"Pharmaceutics"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid Lipid Nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/or\/v33n1\/59095\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:21:35Z","timestamp":1741328495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n1\/59095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.053069","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}